Pediatrics First: How Day One Bio Is Flipping the Script on Cancer Drug Developmenthttps://lnkd.in/eEC2d2rt Discover how Day One Bio is redefining cancer drug development by prioritizing pediatric patients first—and how the FDA’s Priority Review Voucher program plays into their strategy.
关于我们
Life Science Leader magazine is an essential business journal for life science executives who work for everything from emerging biotechs to Big Pharmas. Our content is designed to inform readers of industry best practices and motivate them to implement those practices in their businesses. Each month, Life Science Leader features interviews with executives from the leading pharma and biotech companies, including Pfizer, Merck, Daiichi Sankyo, Genentech, Genzyme, Eli Lilly, and Janssen, as well as the FDA and more. This exclusive thought leadership provides an in-depth look into industry trends and hot topics that will impact the growth of the pharma and biopharma markets. As the market is continually growing and innovating, these insights provide readers with actionable information and strategies to implement when navigating the evolving clinical, manufacturing, entrepreneurial, and regulatory landscapes. Life Science Leader is part of Life Science Connect. Life Science Connect Mission: To connect the people, ideas, and organizations needed to advance the development of pharmaceuticals, biologics, diagnostics, and medical devices that improve the human condition so that they can be brought to market in a safe and cost-effective manner.
- 网站
-
https://www.lifescienceleader.com
Life Science Leader的外部链接
- 所属行业
- 图书期刊出版业
- 规模
- 11-50 人
- 总部
- Erie，PA
- 类型
- 私人持股
- 创立
- 2009
- 领域
- Magazine Publishing、Pharmaceutical Business、Biopharmaceutical Business和Biotech
地点
-
主要
获取路线
5340 Fryling Rd.
Suite 100
US，PA，Erie，16510
Life Science Leader员工
动态
-
Resetting The Immune System For Lasting Remission https://lnkd.in/ehEMBX2Z - By Iain Kilty How do we move beyond alleviating the signs and symptoms of disease to achieve lasting, functional cures and address the large unmet medical need that persists for these patient populations?
-
-
Pharma's Guide To Making Health Communications Land Well https://lnkd.in/ehsUfqup - By Michelle Bridenbaker Breaking through all of this ‘noise,’ with targeted and credible messaging that hits its mark, is no mean feat.
-
-
Testing Federal Healthcare Laws: Risks In Genetic-Testing Programs https://lnkd.in/enCTydND - By Adam Braverman, Nathaniel Mendell, Kate Driscoll, and Megan Baffaro Today, the DOJ — relying largely upon whistleblowers — has deployed the False Claims Act (FCA) and the Anti-Kickback Statute (AKS) to scrutinize numerous industries accepting government funds, chief among them the healthcare industry.
-
-
AI In A Time Of Uncertainty: Key Strategies To Enable Flexibility https://lnkd.in/eMHkizQn - By Gaugarin "G" Oliver, founder and CEO, CapeStart Organizational Goals For AI And Performance Improvement -
-
-
How Are Emerging Technologies Transforming Cell Therapy Manufacturing? Join Cell & Gene Live on Thursday for an insightful discussion on the latest manufacturing innovations shaping cell therapy production. Our expert panel will cover: ? Automation solutions to boost efficiency & scalability ? Strategies to optimize cell therapy delivery Featuring industry leaders: ?? Rohit Ingale, Head of Manufacturing & MSAT, Arcellx ?? David O'Donnell, VP, Head of Manufacturing, Vor Bio ?? Erin Harris, Chief Editor, Cell & Gene Learn how these technologies are tackling key manufacturing challenges! ?? Save your spot: https://lnkd.in/e5bhxVv2
-
-
Interchangeability In Leadership: A Career Built On Versatility https://lnkd.in/es9j9k77 - By Mary Beth Sandin Adaptability serves as the foundation for lasting success, shaping leaders who can thrive in an ever-changing business landscape.
-
-
Courtroom Clash: Inside The High-Stakes World Of mRNA Patent Litigation https://lnkd.in/e3TJEVAz - By Anna Rose Welch Innovation can be complicated when you’re trying to avoid infringing other companies’ innovations.
-
-
An Updated View of The Federal Segment: DHA Formulary Management https://lnkd.in/etZe8SDQ - By Shannon Matwiyoff and Cheryl Middleton "For prescriptions requiring prior authorization currently being adjudicated, the process can be laborious. My experience with this is that the length of time for the wait is drug dependent. It is also drug urgency dependent and of course cost dependent.”- DOD physician perspective on shift to ESI utilization management at the MTF level
-
-
AI In A Time Of Uncertainty: Key Strategies To Enable Flexibility https://lnkd.in/eq88Yvf9 - By Gaugarin "G" Oliver, founder and CEO, CapeStart Organizational Goals For AI And Performance Improvement
-